Inflammation drives a broad spectrum of human diseases. Professor Emma Guttman, a leading expert in inflammatory skin diseases, discusses why inflammatory protein biomarker analysis is revolutionising her research field. She sees Olink as the agent of change for how we understand and treat inflammatory skin diseases. Learn more about how protein biomarkers can transform your inflammation research: https://bit.ly/3yOsyUq
BiopharmaMolecular BiologyPersonalized MedicineProteomics and Metabolomics